FY2024 · ended Jun 30, 2024 · Revenue $4.98M, +6.4% YoY · Filed Oct 25, 2024
Procyon Corporation (PCYN) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2024, which ended Jun 30, 2024, it reported revenue of $5.0 million and a net loss of $341,140. Free cash flow was -$125,163. As of Jun 30, 2024 it held $326,143 in cash and investments and $319,876 in total debt.
Revenue
$4.98M
+6.4% vs prior year
Net income
$-341,140
-579.0% vs prior year
Operating cash flow
$-61,251
-142.1% vs prior year
Free cash flow
$-125,163
-261.0% vs prior year
EPS
$-0.04
-300.0% vs prior year
Dividend per share
None
Shares outstanding
8.12M
+0.4% vs prior year
Net cash
$6,267
FY 2024
Operating margin
-4.6%
FY 2024
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PCYN (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- CO
- Headquarters
- Clearwater, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 812306
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2024 Jun 30, 2024 |
FY 2023 Jun 30, 2023 |
FY 2022 Jun 30, 2022 |
FY 2021 Jun 30, 2021 |
FY 2020 Jun 30, 2020 |
|---|---|---|---|---|---|
| Revenue | $5.0M | $4.7M | $4.8M | $4.7M | $4.3M |
| Operating income | -$231,705 | -$97,381 | -$237,215 | $226,674 | $153,016 |
| Net income | -$341,140 | -$50,245 | -$209,790 | $694,349 | $111,658 |
| Diluted EPS | -$0.04 | -$0.01 | -$0.03 | $0.08 | $0.01 |
| Operating cash flow | -$61,251 | $145,466 | -$383,482 | $279,500 | $198,772 |
| Free cash flow | -$125,163 | -$34,672 | -$466,126 | $214,334 | $175,728 |
| Total assets | $3.2M | $3.6M | $3.8M | $4.3M | $2.8M |
| Total liabilities | $917,122 | $946,002 | $1.1M | $1.4M | $657,925 |
| Stockholders' equity | $2.3M | $2.6M | $2.7M | $2.9M | $2.2M |
| Cash and investments | $326,143 | $451,306 | $760,396 | $1.2M | $665,834 |
| Total debt | $319,876 | $493,447 | $653,859 | $807,882 | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 8, 2024 | Nov 8, 2024 |
| 10-K | Annual report | Oct 25, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Other events
|
Oct 22, 2024 | Oct 22, 2024 |
| 10-Q | Quarterly report | May 24, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Feb 22, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | Nov 22, 2023 | Sep 30, 2023 |
All 297 Procyon Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.